I am a
Home I AM A Search Login

Papers of the Week


Ther Adv Drug Saf


Safety evaluation of intravenous immunoglobulin in pediatric patients: a retrospective, 1-year observational study.


Elajez R, Ezzeldin A, Gaber H
Ther Adv Drug Saf. 2019; 10:2042098619876736.
PMID: 31620272.


Intravenous immunoglobulin (IVIG) is a pooled human plasma protein that has shown efficacy in treating a variety of disorders. IVIG is generally well tolerated and has a good safety profile. There are various IVIG products available on the market, which results in differences in efficacy and safety profile. The aim of this study was to assess the safety profile of IVIG use in pediatric patients and its association with other predicted factors.